Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 151

1.

Yield of peritoneal cytology in staging patients with gastric and gastroesophageal cancer.

Allen CJ, Newhook TE, Vreeland TJ, Das P, Minsky BD, Blum M, Song S, Ajani J, Ikoma N, Mansfield PF, Roy-Chowdhuri S, Badgwell BD.

J Surg Oncol. 2019 Dec;120(8):1350-1357. doi: 10.1002/jso.25729. Epub 2019 Oct 14.

PMID:
31612494
2.

Prognostic Value of Lymph Node Yield After Neoadjuvant Chemoradiation for Gastric Cancer.

Allen CJ, Vreeland TJ, Newhook TE, Das P, Minsky BD, Blum M, Ajani J, Ikoma N, Mansfield PF, Badgwell BD.

Ann Surg Oncol. 2019 Sep 24. doi: 10.1245/s10434-019-07840-8. [Epub ahead of print]

PMID:
31552618
3.

Surgeon Assessment of Gastric Cancer Lymph Node Specimens with a Video of Technique.

Ikoma N, Estrella JS, Hofstetter WL, Ajani JA, Fournier KF, Mansfield PF, Skibber JM, Badgwell BD.

J Gastrointest Surg. 2018 Nov;22(11):2013-2019. doi: 10.1007/s11605-018-3880-0. Epub 2018 Jul 27.

PMID:
30054780
4.

The ypT category does not impact overall survival in node negative gastric cancer.

Ikoma N, Hofstetter WL, Estrella JS, Das P, Minsky BD, Fournier KF, Mansfield PF, Ajani JA, Badgwell BD.

J Surg Oncol. 2018 Jun;117(8):1721-1728. doi: 10.1002/jso.25081. Epub 2018 Jun 27.

PMID:
29949666
5.

Patient Selection for Cytoreductive Surgery.

Grotz TE, Fournier KF, Mansfield PF.

Surg Oncol Clin N Am. 2018 Jul;27(3):443-462. doi: 10.1016/j.soc.2018.02.012. Review.

PMID:
29935682
6.

Comment on: External Validation of the Simplified Preoperative Assessment for Low-Grade Mucinous Adenocarcinoma of the Appendix.

Dineen SP, Royal RE, Mansfield PF, Fournier KF.

Ann Surg Oncol. 2017 Dec;24(Suppl 3):627. doi: 10.1245/s10434-017-6218-3. Epub 2017 Nov 9. No abstract available.

PMID:
29124485
7.

Patterns of relapse in patients with localized gastric adenocarcinoma who had surgery with or without adjunctive therapy: costs and effectiveness of surveillance.

Elimova E, Slack RS, Chen HC, Planjery V, Shiozaki H, Shimodaira Y, Charalampakis N, Lin Q, Harada K, Wadhwa R, Estrella JS, Kaya DM, Sagebiel T, Lee JH, Weston B, Bhutani M, Murphy MB, Matamoros A, Minsky B, Das P, Mansfield PF, Badgwell BD, Ajani JA.

Oncotarget. 2017 Jul 13;8(46):81430-81440. doi: 10.18632/oncotarget.19226. eCollection 2017 Oct 6.

8.

Stratification of outcomes for mucinous appendiceal adenocarcinoma with peritoneal metastasis by histological grade.

Grotz TE, Royal RE, Mansfield PF, Overman MJ, Mann GN, Robinson KA, Beaty KA, Rafeeq S, Matamoros A, Taggart MW, Fournier KF.

World J Gastrointest Oncol. 2017 Sep 15;9(9):354-362. doi: 10.4251/wjgo.v9.i9.354.

9.

Utility of Appendiceal Calcifications Detected on Computed Tomography as a Predictor for an Underlying Appendiceal Epithelial Neoplasm.

Sagebiel TL, Mohamed A, Matamoros A, Taggart MW, Doamekpor F, Raghav KP, Mann GN, Mansfield PF, Eng C, Royal RE, Foo WC, Ensor JE, Fournier KF, Overman MJ.

Ann Surg Oncol. 2017 Nov;24(12):3667-3672. doi: 10.1245/s10434-017-6052-7. Epub 2017 Aug 22.

PMID:
28831698
10.

Left Gastric Artery Lymph Nodes Should Be Included in D1 Lymph Node Dissection in Gastric Cancer.

Ikoma N, Blum M, Estrella JS, Wang X, Fournier KF, Mansfield PF, Ajani JA, Badgwell BD.

J Gastrointest Surg. 2017 Oct;21(10):1563-1570. doi: 10.1007/s11605-017-3539-2. Epub 2017 Aug 17.

PMID:
28819789
11.

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Moderately and Poorly Differentiated Appendiceal Adenocarcinoma: Survival Outcomes and Patient Selection.

Grotz TE, Overman MJ, Eng C, Raghav KP, Royal RE, Mansfield PF, Mann GN, Robinson KA, Beaty KA, Rafeeq S, Matamoros A, Taggart MW, Fournier KF.

Ann Surg Oncol. 2017 Sep;24(9):2646-2654. doi: 10.1245/s10434-017-5938-8. Epub 2017 Jul 10.

PMID:
28695394
12.

Multimodality Treatment of Gastric Lymphoma.

Ikoma N, Badgwell BD, Mansfield PF.

Surg Clin North Am. 2017 Apr;97(2):405-420. doi: 10.1016/j.suc.2016.11.012. Epub 2017 Feb 14. Review.

PMID:
28325194
13.

Co-morbidities Rather than Age Impact Outcomes in Patients Receiving Preoperative Therapy for Gastroesophageal Adenocarcinoma.

Charalampakis N, Xiao L, Lin Q, Elimova E, Shimodaira Y, Harada K, Rogers JE, Mares J, Amlashi FG, Minsky BD, Das P, Hofstetter WL, Matamoros A Jr, Sagebiel TL, Blum-Murphy MA, Lee JH, Weston B, Bhutani MS, Mansfield PF, Estrella JS, Badgwell BD, Ajani JA.

Ann Surg Oncol. 2017 Aug;24(8):2291-2301. doi: 10.1245/s10434-016-5601-9. Epub 2016 Oct 21.

PMID:
27770339
14.

Intrathoracic Chemoperfusion Decreases Recurrences in Patients with Full-Thickness Diaphragm Involvement with Mucinous Appendiceal Adenocarcinoma.

Grotz TE, Mansfield PF, Royal RE, Mann GN, Rafeeq S, Beaty KA, Overman MJ, Fournier KF.

Ann Surg Oncol. 2016 Sep;23(9):2914-9. doi: 10.1245/s10434-016-5209-0. Epub 2016 Mar 30.

PMID:
27027310
15.

Prognosis of gastric adenocarcinoma patients with various burdens of peritoneal metastases.

Shiozaki H, Elimova E, Slack RS, Chen HC, Staerkel GA, Sneige N, Shimodaira Y, Sagebiel T, Lee JH, Bhutani MS, Das P, Mansfield PF, Estrella JS, Badgwell BD, Ajani JA.

J Surg Oncol. 2016 Jan;113(1):29-35. doi: 10.1002/jso.24087. Epub 2015 Nov 25.

PMID:
26603684
16.

Defining the Impact of Surgical Approach on Perioperative Outcomes for Patients with Gastric Cardia Malignancy.

Day RW, Badgwell BD, Fournier KF, Mansfield PF, Aloia TA.

J Gastrointest Surg. 2016 Jan;20(1):146-53; discussion 153. doi: 10.1007/s11605-015-2949-2. Epub 2015 Sep 28.

PMID:
26416411
17.

Feeding tube placement during cytoreductive surgery and heated intraperitoneal chemotherapy does not improve postoperative nutrition and is associated with longer length of stay and higher readmission rates.

Dineen SP, Robinson KA, Roland CL, Beaty KA, Rafeeq S, Mansfield PF, Royal RE, Fournier KF.

J Surg Res. 2016 Jan;200(1):158-63. doi: 10.1016/j.jss.2015.08.003. Epub 2015 Aug 13.

PMID:
26342838
18.

Goblet cell carcinoid tumor, mixed goblet cell carcinoid-adenocarcinoma, and adenocarcinoma of the appendix: comparison of clinicopathologic features and prognosis.

Taggart MW, Abraham SC, Overman MJ, Mansfield PF, Rashid A.

Arch Pathol Lab Med. 2015 Jun;139(6):782-90. doi: 10.5858/arpa.2013-0047-OA.

PMID:
26030247
19.

A Simplified Preoperative Assessment Predicts Complete Cytoreduction and Outcomes in Patients with Low-Grade Mucinous Adenocarcinoma of the Appendix.

Dineen SP, Royal RE, Hughes MS, Sagebiel T, Bhosale P, Overman M, Matamoros A, Mansfield PF, Fournier KF.

Ann Surg Oncol. 2015 Oct;22(11):3640-6. doi: 10.1245/s10434-015-4446-y. Epub 2015 Feb 20.

20.

Improved Survival with Anti-VEGF Therapy in the Treatment of Unresectable Appendiceal Epithelial Neoplasms.

Choe JH, Overman MJ, Fournier KF, Royal RE, Ohinata A, Rafeeq S, Beaty K, Phillips JK, Wolff RA, Mansfield PF, Eng C.

Ann Surg Oncol. 2015 Aug;22(8):2578-84. doi: 10.1245/s10434-014-4335-9. Epub 2015 Jan 13.

PMID:
25582740
21.

Serious postoperative infections following resection of common solid tumors: outcomes, costs, and impact of hospital surgical volume.

Avritscher EB, Cooksley CD, Rolston KV, Swint JM, Delclos GL, Franzini L, Swisher SG, Walsh GL, Mansfield PF, Elting LS.

Support Care Cancer. 2014 Feb;22(2):527-35. doi: 10.1007/s00520-013-2006-1. Epub 2013 Oct 19.

PMID:
24141699
22.

Giant hepatic hemangioma masquerading as a gastric subepithelial tumor.

Kochar R, Atiq M, Lee JH, Landon G, Mansfield PF, Bhutani MS.

Gastroenterol Hepatol (N Y). 2013 Jun;9(6):396-8. No abstract available.

23.

High-level microsatellite instability in appendiceal carcinomas.

Taggart MW, Galbincea J, Mansfield PF, Fournier KF, Royal RE, Overman MJ, Rashid A, Abraham SC.

Am J Surg Pathol. 2013 Aug;37(8):1192-200. doi: 10.1097/PAS.0b013e318282649b.

24.

Pathologic complete response in poorly differentiated adenocarcinomas of the appendix: a case series.

Bilen MA, Taggart MW, Fournier K, Ellis LM, Mansfield PF, Eng C, Royal RE, Overman MJ.

Acta Oncol. 2013 Jun;52(5):1044-6. doi: 10.3109/0284186X.2012.724772. Epub 2012 Oct 1. No abstract available.

PMID:
23020527
25.

Localized gastric cancer treated with chemoradation without surgery: UTMD Anderson Cancer Center experience.

Suzuki A, Xiao L, Taketa T, Blum MA, Matamoros A Jr, Chien PL, Mansfield PF, Fournier KF, Weston B, Lee JH, Bhutani MS, Estrella JS, Delclos ME, Krishnan S, Das P, Ajani JA.

Oncology. 2012;82(6):347-51. doi: 10.1159/000338318. Epub 2012 Jun 2.

PMID:
22677933
26.

Surgical approaches to gastric cancer.

Russell MC, Mansfield PF.

J Surg Oncol. 2013 Mar;107(3):250-8. doi: 10.1002/jso.23180. Epub 2012 Jun 4. Review.

PMID:
22674546
27.

Intensity-modulated radiation therapy with concurrent chemotherapy as preoperative treatment for localized gastric adenocarcinoma.

Chakravarty T, Crane CH, Ajani JA, Mansfield PF, Briere TM, Beddar AS, Mok H, Reed VK, Krishnan S, Delclos ME, Das P.

Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):581-6. doi: 10.1016/j.ijrobp.2011.07.035. Epub 2011 Dec 2.

PMID:
22137021
28.

Multimodality approaches to localized gastric cancer.

Das P, Jiang Y, Lee JH, Bhutani MS, Ross WA, Mansfield PF, Ajani JA.

J Natl Compr Canc Netw. 2010 Apr;8(4):417-25.

PMID:
20410334
29.

Conditional survival estimates improve over 5 years for melanoma survivors with node-positive disease.

Bowles TL, Xing Y, Hu CY, Mungovan KS, Askew RL, Chang GJ, Gershenwald JE, Lee JE, Mansfield PF, Ross MI, Cormier JN.

Ann Surg Oncol. 2010 Aug;17(8):2015-23. doi: 10.1245/s10434-010-1051-y. Epub 2010 Apr 6.

PMID:
20369298
30.

Conditional survival estimates improve over time for patients with advanced melanoma: results from a population-based analysis.

Xing Y, Chang GJ, Hu CY, Askew RL, Ross MI, Gershenwald JE, Lee JE, Mansfield PF, Lucci A, Cormier JN.

Cancer. 2010 May 1;116(9):2234-41. doi: 10.1002/cncr.24966.

31.

Autologous tumor-derived heat-shock protein peptide complex-96 (HSPPC-96) in patients with metastatic melanoma.

Eton O, Ross MI, East MJ, Mansfield PF, Papadopoulos N, Ellerhorst JA, Bedikian AY, Lee JE.

J Transl Med. 2010 Jan 29;8:9. doi: 10.1186/1479-5876-8-9.

32.

Modern systemic chemotherapy in surgically unresectable neoplasms of appendiceal origin: a single-institution experience.

Shapiro JF, Chase JL, Wolff RA, Lambert LA, Mansfield PF, Overman MJ, Ohinata A, Liu J, Wang X, Eng C.

Cancer. 2010 Jan 15;116(2):316-22. doi: 10.1002/cncr.24715.

33.

Patient with advanced gastric cancer responds twice to the same systemic therapy.

Lagaly R, Horak A, Lee JH, Mansfield PF, Ajani JA.

Gastrointest Cancer Res. 2009 May;3(3):115-7. No abstract available.

34.

Incidence, risk factors, and impact of severe neutropenia after hyperthermic intraperitoneal mitomycin C.

Lambert LA, Armstrong TS, Lee JJ, Liu S, Katz MH, Eng C, Wolff RA, Tortorice ML, Tansey P, Gonzalez-Moreno S, Lambert DH, Mansfield PF.

Ann Surg Oncol. 2009 Aug;16(8):2181-7. doi: 10.1245/s10434-009-0523-4. Epub 2009 May 28.

35.

A randomized phase III trial of biochemotherapy versus interferon-alpha-2b for adjuvant therapy in patients at high risk for melanoma recurrence.

Kim KB, Legha SS, Gonzalez R, Anderson CM, Johnson MM, Liu P, Papadopoulos NE, Eton O, Plager C, Buzaid AC, Prieto VG, Hwu WJ, Frost AM, Alvarado G, Hwu P, Ross MI, Gershenwald JE, Lee JE, Mansfield PF, Benjamin RS, Bedikian AY.

Melanoma Res. 2009 Feb;19(1):42-9. doi: 10.1097/CMR.0b013e328314b84a.

PMID:
19430405
36.

Lymph node ratio predicts disease-specific survival in melanoma patients.

Xing Y, Badgwell BD, Ross MI, Gershenwald JE, Lee JE, Mansfield PF, Lucci A, Cormier JN.

Cancer. 2009 Jun 1;115(11):2505-13. doi: 10.1002/cncr.24290.

37.

Radiation therapy field extent for adjuvant treatment of axillary metastases from malignant melanoma.

Beadle BM, Guadagnolo BA, Ballo MT, Lee JE, Gershenwald JE, Cormier JN, Mansfield PF, Ross MI, Zagars GK.

Int J Radiat Oncol Biol Phys. 2009 Apr 1;73(5):1376-82. doi: 10.1016/j.ijrobp.2008.06.1910. Epub 2008 Sep 5.

PMID:
18774657
38.

Phase II trial of imatinib mesylate in patients with metastatic melanoma.

Kim KB, Eton O, Davis DW, Frazier ML, McConkey DJ, Diwan AH, Papadopoulos NE, Bedikian AY, Camacho LH, Ross MI, Cormier JN, Gershenwald JE, Lee JE, Mansfield PF, Billings LA, Ng CS, Charnsangavej C, Bar-Eli M, Johnson MM, Murgo AJ, Prieto VG.

Br J Cancer. 2008 Sep 2;99(5):734-40. doi: 10.1038/sj.bjc.6604482. Epub 2008 Aug 19.

39.

Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma.

Gershenwald JE, Andtbacka RH, Prieto VG, Johnson MM, Diwan AH, Lee JE, Mansfield PF, Cormier JN, Schacherer CW, Ross MI.

J Clin Oncol. 2008 Sep 10;26(26):4296-303. doi: 10.1200/JCO.2007.15.4179. Epub 2008 Jul 7.

40.

Fibrin sealant does not decrease seroma output or time to drain removal following inguino-femoral lymph node dissection in melanoma patients: a randomized controlled trial (NCT00506311).

Mortenson MM, Xing Y, Weaver S, Lee JE, Gershenwald JE, Lucci A, Mansfield PF, Ross MI, Cormier JN.

World J Surg Oncol. 2008 Jun 18;6:63. doi: 10.1186/1477-7819-6-63.

41.

The impact of ethnicity on the presentation and prognosis of patients with gastric adenocarcinoma. Results from the National Cancer Data Base.

Al-Refaie WB, Tseng JF, Gay G, Patel-Parekh L, Mansfield PF, Pisters PW, Yao JC, Feig BW.

Cancer. 2008 Aug 1;113(3):461-9. doi: 10.1002/cncr.23572.

42.

Chemoradiation therapy for potentially resectable gastric cancer: clinical outcomes among patients who do not undergo planned surgery.

Kim MM, Mansfield PF, Das P, Janjan NA, Badgwell BD, Phan AT, Delclos ME, Maru D, Ajani JA, Crane CH, Krishnan S.

Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):167-72. doi: 10.1016/j.ijrobp.2007.09.019.

PMID:
18406886
43.

Prospective assessment of the reliability, validity, and sensitivity to change of the Functional Assessment of Cancer Therapy-Melanoma questionnaire.

Cormier JN, Ross MI, Gershenwald JE, Lee JE, Mansfield PF, Camacho LH, Kim K, Webster K, Cella D, Palmer JL.

Cancer. 2008 May 15;112(10):2249-57. doi: 10.1002/cncr.23424.

44.

Adjuvant high-dose interferon for cutaneous melanoma is most beneficial for patients with early stage III disease.

Anaya DA, Xing Y, Feng L, Huang X, Camacho LH, Ross MI, Gershenwald JE, Lee JE, Mansfield PF, Cormier JN.

Cancer. 2008 May 1;112(9):2030-7. doi: 10.1002/cncr.23399.

45.

Melanoma adrenal metastasis: natural history and surgical management.

Mittendorf EA, Lim SJ, Schacherer CW, Lucci A, Cormier JN, Mansfield PF, Gershenwald JE, Ross MI, Lee JE.

Am J Surg. 2008 Mar;195(3):363-8; discussion 368-9. doi: 10.1016/j.amjsurg.2007.12.018.

PMID:
18206850
46.

Incidence, natural history, and patterns of locoregional recurrence in gastric cancer patients treated with preoperative chemoradiotherapy.

Reed VK, Krishnan S, Mansfield PF, Bhosale PR, Kim M, Das P, Janjan NA, Delclos ME, Lowy AM, Feig BW, Pisters PW, Ajani JA, Crane CH.

Int J Radiat Oncol Biol Phys. 2008 Jul 1;71(3):741-7. doi: 10.1016/j.ijrobp.2007.10.030. Epub 2007 Dec 31.

47.

Clinical benefit of palliative radiation therapy in advanced gastric cancer.

Kim MM, Rana V, Janjan NA, Das P, Phan AT, Delclos ME, Mansfield PF, Ajani JA, Crane CH, Krishnan S.

Acta Oncol. 2008;47(3):421-7.

PMID:
17899453
48.

Peritoneal dissemination of non-carcinoid primary appendiceal cancer.

Lambert LA, Mansfield PF.

Gynecol Oncol. 2007 Dec;107(3):592; author reply 592-3. Epub 2007 Aug 31. No abstract available.

PMID:
17765296
49.

Cytoreductive surgery and perioperative intraperitoneal chemotherapy for colorectal carcinomatosis: if at first you don't succeed....

Lambert LA, Mansfield PF.

Ann Surg Oncol. 2007 Nov;14(11):3037-9. Epub 2007 Aug 29. No abstract available.

PMID:
17726635
50.

Pneumoperitoneum in the cancer patient.

Badgwell B, Feig BW, Ross MI, Mansfield PF, Wen S, Chang GJ.

Ann Surg Oncol. 2007 Nov;14(11):3141-7. Epub 2007 Aug 7.

PMID:
17680315

Supplemental Content

Loading ...
Support Center